Verrica Pharmaceuticals Inc
VRCA
Company Profile
Business description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Contact
44 West Gay Street
Suite 400
West ChesterPA19380
USAT: +1 484 453-3300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
71
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,453.50 | 31.80 | 0.38% |
| CAC 40 | 7,694.44 | 67.60 | 0.89% |
| DAX 40 | 23,352.69 | 236.73 | 1.02% |
| Dow JONES (US) | 41,368.45 | 254.48 | 0.62% |
| FTSE 100 | 8,531.61 | 27.72 | -0.32% |
| HKSE | 22,716.50 | 59.42 | -0.26% |
| NASDAQ | 17,928.14 | 189.98 | 1.07% |
| Nikkei 225 | 37,478.58 | 549.95 | 1.49% |
| NZX 50 Index | 12,635.46 | 168.43 | 1.35% |
| S&P 500 | 5,663.94 | 32.66 | 0.58% |
| S&P/ASX 200 | 8,224.40 | 32.70 | 0.40% |
| SSE Composite Index | 3,340.73 | 11.27 | -0.34% |